Results 181 to 190 of about 27,616 (251)

Artificial Intelligence and Prostate-Breast Cancer Biology: Recent Advances in Treatments and Perspectives - A Comprehensive Review. [PDF]

Health Sci Rep
Ouma RBO, Ngari SM, Kibet JK.
europepmc   +1 more source

Supportive Care for HDR Brachytherapy in Gynecological Cancer: A Single Center Experience. [PDF]

In Vivo
Meinecke D, Bruns F, Christiansen H, Steinkasserer L, Knöchelmann AC.   +4 more
europepmc   +1 more source

Particle Therapy Co-Operative Group Consensus Statement on Reirradiation With Proton Therapy for Prostate Cancer. [PDF]

Int J Part Ther
Hasan S, Shen X, Giap H, Patel S, Hyde C, Deville C, Gray J, Simone CB, Mendenhall NP, Choi S, Bryant CM.   +10 more
europepmc   +1 more source

Dose-Dependent Dual Effects of Gradient Ionizing Radiation on Neurocognition. [PDF]

Int J Mol Sci
Jian X, Jiang B, Li S, Min T, Xu Y, Xu R, Liu L, He Y.   +7 more
europepmc   +1 more source

Interstitial High-Dose-Rate Brachytherapy for Radiorecurrent Atypical Meningioma: A Brief Report. [PDF]

Adv Radiat Oncol
Delery W, Kim M, Laird R, Jank E, Liu E, Kafka K, Park SJ, Kaprealian T, Chang K, Everson R, Kim W, Savjani R.   +11 more
europepmc   +1 more source

Complex HBB gene editing outcomes revealed by a fluorescent reporter cell model. [PDF]

Mol Ther Nucleic Acids
Karsenty CL, Betancourth D, Cao M, Pham QK, Park SH, Bao G.   +5 more
europepmc   +1 more source

Compact bacterial recombination complexes drive efficient kilobase-scale knock-in in mammalian cells. [PDF]

Nucleic Acids Res
Luo Y, Jiang Q, Qu Y, Li W, Liu R, Zhu Y, Xie Y, Jiang C, Chen C, Cong L, Han F, Bao J, Wang C.   +12 more
europepmc   +1 more source

SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer.

JAMA Netw Open
Udovicich C, Cheung P, Chu W, Chung H, Detsky J, Liu S, Morton G, Tseng CL, Vesprini D, Hudson JM, Ong WL, Kennedy T, Helou J, Davidson M, Ravi A, McGuffin M, Zhang L, Mamedov A, Deabreu A, Kulasingham-Poon M, Loblaw A.   +20 more
europepmc   +1 more source

CRISPR/methotrexate-integrated strategy for TCR-T cell engineering with reduced chromosome 14 loss. [PDF]

Mol Ther Methods Clin Dev
Xu J, Shen L, Chen Z, Zhang C, Ding X, He Q, Zhou X, Jiang P, Liu J, Li L, Fang J, Li F, Wan L, Ding X, Yang Y, Wang X, Wang P, Song X, Zhang Y.   +18 more
europepmc   +1 more source

Retrospective analysis of high-dose-rate brachytherapy for patients with prostate cancer aged ≥ 75 years. [PDF]

BMC Cancer
Matsuda K, Ogata T, Kamitani N, Watanabe K, Tokiya R, Hayashi T, Miyaji Y, Komura K, Tamada T, Katsui K.   +9 more
europepmc   +1 more source